Taipei Medical University

Graduate Institute of Cancer Biology and Drug Discovery

Hung-Yun Lin
https://www.tmu.edu.tw/

Research Field

Medicine

Introduction

I joined Taipei Medical University as a full professor in 2012. Before returning to Taiwan, I worked at the Veteran Institute and a private research institute. For the past ten years, we have published more than 100 research and review papers with Taipei Medical University.

My Google Scholar performance is shown as follows.

All                   Citations are 11,987; h-index: 59; and i10-index: 162.

Since 2019     Citations are 4,631; h-index: 39; and i10-index: 136.

I work with President Yun Yen and Academician Leroy in the PhD program in Cancer Biology and Drug Development first. Academician Academician Jaqueline WhangPeng and Academician Kuan Wang join in our research team later at Taipei Medical University. Our team was awarded an integrated Ministry of Science and Technology (MOST) entitled" Nano-HEVnp Theranostic Strategy for Late-Stage Colorectal Cancer Patients" in 2020. In 2021, we awarded another MOST integrated grant entitled Targeting Theranostic Strategies Against Integrin αvβ3-FAK-Related Signalings in Cholangiocarcinoma. Our next goal is to push our ideas and product to marketing and the new formatting company.


Research Topics

My team's research mainly focuses on the following three different directions: 1. Signaling induced by thyroid hormones and steroid hormones and their impact on cancer development; 2. The role of resveratrol and other natural products in cancer prevention Application; 3. Nanomedicine. Recently, our research has begun to shift from basic science to industry-university collaboration, and we look forward to applying our research results to clinical practice or the market. We are particularly interested in signaling induced by thyroid hormones and steroid hormones and their impact on cancer and other diseases. In order to prevent or treat cancer cell proliferation induced by thyroid hormone or steroid hormones, we began to research and develop a nanomedicine that can be used for targeted cancer therapy. At the same time, we are also studying the biological activities induced by resveratrol and other Chinese herbal medicines. In addition, we are also very interested in the relationship between leptin and obesity and diabetes.


Honor

2010 Sept.       1st International Resveratrol Conference, Elsinore, Denmark

                        Section chair

2016 Nov 17-  Resveratrol 2016 International Conference, Taipei, Taiwan

                        Chairman

2016                Excellent publication award at Taipei Medical University

2017                Enterprise innovation competition for 4 Universities, 1st place award

2017                Enterprise innovation competition Taipei Medical University 1st place award

2017                Enterprise innovation competition Ministry of Education Outstanding

2018                Outstanding publication award at Taipei Medical University First prize

2019                Dr. Ta-Cheng Tung's Basic Cancer Research Award


Educational Background

SUNY at Buffalo                          Ph.D.               1991         Virology

Roswell Park Cancer Institute            Postdoc Fellow       1991-1993         Molecular and Cellular Biology